Here are four key points:
1. The diagnostic test is designed to predict spine deformity and syndrome severity.
2. The test will initially focus on scoliosis.
3. Predictive Biotech is awaiting patent approval of the technology.
4. The company plans to collaborate with spine societies to enhance the technology to meet surgeons’ clinical needs.
More articles on devices:
St. Jude Medical shares increase 0.32%— 4 notes
Histogenics acquires sole development, marketing rights for NeoCart in Japan: 5 key notes
Study: Cartiva SCI an effective for toe osteoarthritis treatment — 4 points
